参考文献: 1.Kidney Int Suppl. 2012;3:S1-S150 2.Kidney International (2024) 105 (Suppl 4S), S117–S314 3.Lv J, Guo L, Wang R, Chen J. Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Nondiabetic Patients w...
参考文献(上下滑动查看) [1] Wong MMY, Tu C, Li Y, et al. Anemia and iron deficiency among chronic kidney disease Stages 3-5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: often unmeasured, variably treated. Clin Kidney J. 2019;13(4):613-624. Published 201...
参考文献: [1]Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117–S314. [2]中华医学会肾脏...
参考文献: Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024 Apr;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018. PMID: 38490803. (▲▼上下滑动查看内容) ...
327 慢性肾脏疾病矿物质骨代谢异常骨 矿物质代谢和钙磷平衡在CKD早期即开始改变,并随肾功能下降而进展,即慢性肾脏疾病矿物质骨代谢异常(ChronicKidneyDiseaseMineraland BoneDisorder,CKDMBD) ,它包括肾性骨营养不良(纤维性骨炎、骨软化症、无动力性骨病)和骨代谢 异常相关性异位钙沉积°K/DOQI指 南建议对 GFR<60mL...
[1] Wong MMY, Tu C, Li Y, et al. Anemia and iron deficiency among chronic kidney disease Stages 3-5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: often unmeasured, variably treated. Clin Kidney J. 2019;13(4):613-624. Published 2019 Aug 3. doi:10.1093...
10.如有其他指征,发生急性脑卒中且有微出血证据的CKD患者,考虑溶栓治疗是合理的。 参考文献:Kelly DM, Ademi Z, Doehner W, et al. Chronic Kidney Disease and Cerebrovascular Disease: Consensus and Guidance From a KDIGO Controversies Conference. Stroke. 2021 Jun 3:STROKEAHA120029680....
chronic kidney diseaseguideline慢性肾脏病(CKD)是全球性公共卫生问题,自2002年美国国家肾脏基金会(NKF)所属"肾脏病预后质量倡议"(K/DOQI)工作组提出了CKD的定义和分期标准以来,该指南对提高全球CKD患者的诊断、治疗水平及改善预后发挥了重大作用。但是,大量根据K/DOQI-CKD诊断标准进行的临床和流行病学研究证据使人们...
1. Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int, 2022, 102(5S):S1-S127. 2. Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2020 Clinical ...
[3]Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2022;102(5S):S1–S127. [4]Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 Clini...